Head-to-head · Value Score
CoreAge Rx vs SkinnyRx
Two GLP-1 deals, scored on the same six factors. CoreAge Rx lands a Value Score of 93, SkinnyRx a 55. Here's who gives you the honest lower price — and where each one bites back.
CoreAge Rx
#1 · Grade A+ · Best Value
Est. first month
$149/mo
Save ~89% vs brand-nameSkinnyRx
#358 · Grade C · Watch List
Est. first month
$349/mo (injectable semaglutide, month-to-month)
Save ~74% vs brand-nameFDA warning letter. The FDA issued SkinnyRx a warning letter in February 2026. Check it on the FDA database.
Get this deal Full SkinnyRx review →The verdict
CoreAge Rx takes it on Value Score, 93 to 55 — an est. $149/mo first month, with no teaser step-up baked in. SkinnyRx isn't out of it: Shoppers who genuinely will commit to eight or twelve months up front, want a tirzepatide tablet or a microdose option, and have read past "as low as" to the $349/$399 month-to-month rates.
CoreAge Rx is also our overall #1 pick across the whole deals board — a flat, all-in price on both molecules in all 50 states. That's why it wins here on the score, not just this matchup.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | CoreAge Rx | SkinnyRx |
|---|---|---|
| Value Score | 93 (A+) | 55 (C) |
| Est. first month | $149/mo | $349/mo (injectable semaglutide, month-to-month) |
| Save vs brand-name | ~89% | ~74% |
| Semaglutide | $149/mo | $349/mo month-to-month (from $199/mo only on the 12-month plan, $2,388 up front) |
| Tirzepatide | $349/mo | $399/mo month-to-month (from $299/mo only on the 12-month plan, $3,588 up front) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | 47 states — excludes AL, MS and LA on every product; no served-states list is published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
CoreAge Rx
The honest lowest price: both molecules at one flat, all-in monthly rate that never steps up after month one.
Why it's a deal
- Flat, all-in monthly price with no intro-rate step-ups after month one
- Both compounded semaglutide and tirzepatide on one account
- Available in all 50 states
- Straightforward, low-friction cancellation — no lock-in
The fine print
- Not the rock-bottom sticker — a couple of teaser tiers advertise lower month-one rates
- No FDA-approved brand-name option (compounded only)
- Does not yet publicly name its 503A/B pharmacy partner
SkinnyRx
The widest compounded GLP-1 catalogue we track — both molecules, injectable and tablet, plus a real microdose line — sold entirely behind twelve-month rates presented as monthly ones.
Why it's a deal
- Unusually broad catalogue: compounded semaglutide and tirzepatide, each as an injection and as a tablet, plus dedicated microdose versions of both injectables
- A compounded tirzepatide TABLET — a genuinely uncommon product that most of the field does not offer at all
- Every rung of every plan is published in the storefront's own price data before any intake quiz, so the full ladder can be checked without handing over your details
- No separate membership fee on the GLP-1 line, and the price is stated as the same at every dose, so titrating up does not raise the bill
- Free overnight shipping, Affirm financing, HSA/FSA eligibility and a 90-day money-back guarantee
The fine print
- ⚠ Every advertised price is the longest-commitment rung, shown under the words "As low as". Month-to-month is $349 semaglutide and $399 tirzepatide — roughly 75% and 34% above the headline — and is printed on no page of the site
- The struck-through $329 beside injectable semaglutide matches no plan on its ladder ($199/$249/$299/$349)
- The FDA issued this operator a warning letter in February 2026 — it is on the public FDA warning-letter database
- Not available in Alabama, Mississippi or Louisiana, and no served-states list is published anywhere on the site
- The Wegovy® and Foundayo™ pills the storefront advertises both show "Unavailable", and no brand tirzepatide is sold at all — the $49 attached to them is a membership fee, not a medication price
- No corporate entity, no named compounding pharmacy and no LegitScript ID are published — 503A is referenced only generically in the FAQ
- Compounded semaglutide and tirzepatide are not FDA-approved
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores CoreAge Rx is ranked on the CoreAge Rx alternatives board, and the same list for the other side is on alternatives to SkinnyRx.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.